文献速递临床试验与 GCP

SToICAL试验:皮质类固醇联合与不联合局麻药软组织注射后疼痛的非劣效性随机对照试验研究方案

The SToICAL trial: study protocol for the soft tissue injection of corticosteroid and local anaesthetic trial-a single site, non-inferiority randomised control trial evaluating pain after soft tissue corticosteroid injections with and without local anaesthetic.
PubMed 文献 · Trials · 2021-09-28

SToICAL试验为单中心、患者与评估者设盲的非劣效性随机对照试验,纳入临床诊断为扳机指、桡骨茎突狭窄性腱鞘炎或腕管综合征的患者,比较1 ml曲安奈德(40 mg/1 ml)联合或不联合1 ml 1%利多卡因注射后疼痛VAS评分差异,主要终点为注射后1小时疼痛VAS均值变化,计划样本量100例。

要点

  • 比较曲安奈德联合利多卡因与单用曲安奈德注射后24小时内疼痛VAS评分。
  • 主要终点为注射后1小时疼痛VAS均值变化,非劣效界值20 mm。
  • 纳入扳机指、桡骨茎突狭窄性腱鞘炎或腕管综合征的成年患者。

核心结论

  • 旨在验证手和腕部皮质类固醇注射后24小时内疼痛不劣于联合局麻药注射。

研究设计与样本

  • 单中心、患者与评估者设盲的非劣效性随机对照试验。
  • 纳入临床诊断扳机指、桡骨茎突狭窄性腱鞘炎或腕管综合征患者,计划样本量100例(含20%脱落率)。
  • 按95%把握度、非劣效界值20 mm、假设标准差25 mm计算样本量。

关键数值与推荐

  • 注射药物为1 ml曲安奈德(40 mg/1 ml),联合或不联合1 ml 1%利多卡因。
  • 主要终点为注射后1小时疼痛VAS均值变化,非劣效界值20 mm。
  • 疼痛VAS在注射前、注射时及注射后5分钟、1小时、2小时、3小时和24小时评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Corticosteroid injections are used in the treatment of hand and wrist conditions. The co-administration of a local anaesthetic and corticosteroid aims to reduce pain after the injection, although no studies have directly compared this with using corticosteroid alone. The aim is to determine whether pain experienced during the 24 h after a corticosteroid injection to the hand and wrist is no worse than (not inferior to) the pain experienced after a corticosteroid and local anaesthetic injection. METHODS: A single-site, patient- and assessor-blinded, non-inferiority randomised control trial recording pain visual analogue scale (VAS) scores in patients with a clinical diagnosis of trigger finger, de Quervains tenosynovitis or carpal tunnel syndrome, treated with a 1-ml triamcinolone (40 mg/1 ml) injection co-administered with or without 1 ml of 1% lidocaine. The primary aim is to investigate a difference in pain VAS scores at 1 h after the injection using a mean change score. A 95% power calculation was made using a minimally clinical important difference of 20 mm as the clinically admissible margin of non-inferiority and an assumed standard deviation of 25 mm, from previous studies. Including a 20% fall out rate, 100 patients are required. DISCUSSION: Patients with a clinical diagnosis of trigger finger, de Quervains and carpal tunnel syndrome, are over the age 18 years old and who are able to give written informed consent will be included. Patients will be excluded if they have had previous surgery or corticosteroid injection for the condition being treated at the site considered for injection. Patients will be electronically randomised and injections delivered during their clinic appointment. Pain is assessed using a 100-mm VAS score taken, before and at the time of injection and at 5 min, 1 h, 2 h, 3 h and 24 h after the injection. The secondary outcomes are to determine a difference in pain VAS score at the time of injection and during the 24 h after. TRIAL REGISTRATION: This study is registered on the IRAS (259336) on November 11, 2019, and EudraCT database on October 31, 2019 (2019-003742-32). REC/HRA approval was given in January 2020, and Clinical Trial Authorisation from the MHRA was given in December 2019. The study is registered on ClinicalTrials.gov ( NCT04253457 ) on February 5, 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Jones M, Evans J, Fullilove S, et al. The SToICAL trial: study protocol for the soft tissue injection of corticosteroid and local anaesthetic trial-a single site, non-inferiority randomised control trial evaluating pain after soft tissue corticosteroid injections with and without local anaesthetic. Trials. 2021. PMID: 34583762. doi:10.1186/s13063-021-05627-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。